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Abstract
Background: The identification of robust lists of molecular biomarkers related to a disease is a fundamental step
for early diagnosis and treatment. However, methodologies for biomarker discovery using microarray data often
provide results with limited overlap. It has been suggested that one reason for these inconsistencies may be that
in complex diseases, such as cancer, multiple genes belonging to one or more physiological pathways are
associated with the outcomes. Thus, a possible approach to improve list stability is to integrate biological
information from genomic databases in the learning process; however, a comprehensive assessment based on
different types of biological information is still lacking in the literature. In this work we have compared the effect of
using different biological information in the learning process like functional annotations, protein-protein
interactions and expression correlation among genes.
Results: Biological knowledge has been codified by means of gene similarity matrices and expression data linearly
transformed in such a way that the more similar two features are, the more closely they are mapped. Two
semantic similarity matrices, based on Biological Process and Molecular Function Gene Ontology annotation, and
geodesic distance applied on protein-protein interaction networks, are the best performers in improving list
stability maintaining almost equal prediction accuracy.
Conclusions: The performed analysis supports the idea that when some features are strongly correlated to each
other, for example because are close in the protein-protein interaction network, then they might have similar
importance and are equally relevant for the task at hand. Obtained results can be a starting point for additional
experiments on combining similarity matrices in order to obtain even more stable lists of biomarkers. The
implementation of the classification algorithm is available at the link: http://www.math.unipd.it/dasan/biomarkers.
html.
Background
Analysis of gene expression from microarray experi-
ments has been widely used for the development of new
physiological hypotheses useful for answering to both
diagnostic and prognostic questions. In the last decade,
supervised classification analysis has experienced a large
diffusion to address this task and several different meth-
ods like discriminant analysis, random forests and
support vector machines among others, have been used
on gene expression data, especially in cancer studies
[1,2].
In these studies, the biological interest is mainly
focused on biomarker discovery, i.e. in finding those
genes and proteins which can be used as diagnostic/
prognostic markers for the disease. Biomarkers provide
useful insight for a deeper and more detailed under-
standing of the biological processes involved in the spe-
cific pathology and might represent the targets for drug
development [3]. Although high accuracy is often
achieved in classification approaches, biomarker lists
obtained in different studies for the same clinical type of
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patients have few genes in common [4,5], whereas bio-
marker reproducibility is fundamental for clinical and
pharmaceutical applications. Several works have recently
pointed out that high reproducibility of biomarker lists
is equally important as high classification accuracy [6,7].
In general, there are two stability issues arising in gene
expression classification and analysis. Firstly, since train-
ing data are often scarce, predictive models obtained
from different datasets can be extremely different. Sec-
ondly, since the number of features is generally very
high, then features can be combined in many different
ways to give solutions able to explain the data. As a
consequence of this, many possible sets of features can
be considered relevant to the task and equally good in
terms of the accuracy. This characteristic makes the
process of selecting the set of relevant features for a
classification task a very hard problem.
Bootstrap methods have been demonstrated helpful in
addressing the first issue. In these approaches different
classifiers are generated and different features (lists of
biomarkers) are selected on different splits of data and
the results are somehow averaged [8,9], thus preserving a
high ranking only to those features that are consistently
the most discriminating features over the splits [10,11].
However, this method does not solve the problem of the
instability due to the high number of features. In fact, the
crucial problem is that the classification task is under
constrained. To address this issue, additional information
available on the relationships between genes should be
used to improve the stability with respect to the features
of the classifiers. The basic idea of this strategy is to take
into account the complex gene relationships, instead of
considering genes as independent features. Several efforts
in this direction have been recently presented in the lit-
erature. In [12], pathway information has been incorpo-
rated into the biomarker discovery process using
available protein-protein interaction networks and con-
sidering subnetworks as features. Logistic regression
models have been applied on expression profiles of two
cohorts of breast cancer patients and results have been
assessed in terms of both agreement between subnet-
works identified in the two datasets and classification
accuracy. In [13-17] topological properties of Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways
[18] or networks reconstructed from gene expression
data have been used to constrain the learning process. In
particular, [16,17] use regularization and integrate prior
knowledge defining KEGG pathway based penalty terms.
The use of Gene Ontology (GO) [19] as prior informa-
tion has been explored in [20], where the authors pro-
pose a classification model based on functional groups of
genes. All the above methods have focused on prediction
performance, without considering in a systematic way the
stability issue. Recent works have started considering the
problem of biomarker list stability [21], but an overview
of the ability of different sources of biological knowledge
to improve the reproducibility of the results is not
already available in the literature.
Our work addresses the integration of prior knowledge
in the learning process and, differently from previous
works, compares the performance of different sources of
prior knowledge. In particular, we propose a standardized
way to incorporate in the kernel different types of biologi-
cal knowledge like functional annotations, protein-protein
interactions, and expression correlation among genes, with
the only constraint that the information is codified by a
similarity matrix. The feature space is then transformed
such that the more similar two features are, the more clo-
sely they are mapped. Similarity matrices are defined using
metrics which are specific for each type of biological infor-
mation used: semantic similarities [22] for the annotations
on GO; topology-based similarity measures [23,24] for
protein-protein interactions (PPI) extracted from Human
Protein Reference Database (HPRD) [25]; pair-wise corre-
lation and mutual information for gene expression data. A
linear classifier resembling the Bayes Point Machine [26]
is used as classification tool. The vector of weights pro-
duced by this algorithm is used to rank the features and
obtain a list of biomarkers.
Differently from approaches that integrate different
datasets [27] by combining kernels [28] to improve classi-
fication performance and robustness of the results thus
considering a different and maybe complementary aspect
of the problem, our approach addresses the integration
of prior knowledge in the learning process. It provides a
standardized way to incorporate different types of biolo-
gical knowledge in the kernel, with the only constraint
that the information is codified by a similarity matrix,
thus it can be used with any kernel method.
As above mentioned, in this work we also compare
the performance of different sources of prior knowledge
and evaluate the performance using three real datasets
from different studies exploring the same clinical classi-
fication task. The assessment of the results obtained for
different similarity matrices is based on the trade-off
between predictive accuracy and feature ranking stabi-
lity, measured using the Canberra distance [7]. In fact,
the introduction of constraints in the feature space
might lead to robust biomarker lists but poor discrimi-
nation between the classes. Finally, we have evaluated
the ability of different biological information to map the
features on new feature spaces where the classes are
more naturally separable.
Methods
Gene expression data
Publicly available data from three breast cancer microar-
ray studies were collected from Gene Expression
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Omnibus (GEO) database [29] with accession numbers:
GSE2990 [30], GSE3494 [31] and GSE7390 [32]. Data-
sets were all hybridized using Affymetrix U133 Gene-
chips™ (HG-U133A). Breast cancer has been
extensively studied in the literature and the Estrogen
receptor (ER) status is the most important prognostic
factor as indicator of response to endocrine therapy
[33]. Estrogen receptor 1 (ESR1) is the gene more
directly associated with ER status and can mask other
potential descriptors of the underlying pathophysiology
[34]; therefore, probesets related to ESR1 were removed
from all datasets. Only tamoxifen-untreated subjects
were selected. Since there are subgroups of samples
belonging to multiple datasets, redundant subjects were
removed. Quality assessment of the raw data from each
dataset was performed using the arrayQualityMetrics
package in Bioconductor [35]. Any array failing quality
controls on MA plots, box-plots and between-array dis-
tances was not considered. Affymetrix chip definition
files were used to annotate the arrays, resulting in 22207
features. Gene expression intensity signal was derived
and normalized independently for each dataset using
robust multiarray average (RMA) algorithm [36]. The
resulting datasets are described in Table 1.
Integration of prior knowledge in the learning process
Expression data are given as very high dimensional vec-
tors of measurements. The high dimensionality makes
the task of biomarkers discovery very hard. This is espe-
cially due to the fact that the task is under constrained.
In this paper, we propose to perform a linear transfor-
mation of the examples (i.e. the biological samples) in a
way that classifiers computed on transformed examples
have a higher stability, hopefully preserving the accu-
racy. This transformation is made by using prior biologi-
cal information about genes in a way to maintain the
structure of the problem.
In this section we first introduce linear classifiers and
some relevant facts about the embedding of data into
feature spaces. Then, we describe our intuition and
describe an algorithm that implements it.
In the following we denote by
{x1, ..., xM} the exam-
ples, i.e. the N dimensional vectors of expression data
obtained for M subjects, where N is the number of genes.
Each example has associated a binary label ym (m = 1,...,
M) having values in {-1,+1}.
Linear classifiers
We focus on linear classifiers which are simple and gen-
erally perform well on gene expression analysis. Given a
linearly separable classification task, there are in general
infinitely many linear classifiers (hyper-planes) that can
correctly classify the examples. This set is commonly
called the version space. When the number of features is
very high, the version space tends to have a large
volume. Formally, the version space for linear classifiers
can be defined as:
V = {w|ym(w · xm) > 0, for each m = 1, ...M,
∥∥w∥∥ = 1} (1)
Without any loss in generality, we consider weights of
unitary norm. A very popular algorithm to find a linear
classifier which correctly separates the training examples
(i.e. an element of the version space) is the Perceptron
algorithm [37] which can be briefly described as in the
following. We assume the training vectors x and w are
of size n, and w is initially set to the zero vector. The
algorithm runs in epochs. On each epoch all the training
examples xi, for i = 1,.., M, are presented to the algo-
rithm and the vector w is updated whenever the asso-
ciated classifier makes a mistake on xi, i.e. if (yi sign(w ·
xi) ≤ 0) then w = w+yixi. When the training set is line-
arly separable, the perceptron is guaranteed to even-
tually converge to a vector (hyper-plane) which correctly
separates the training data, i.e. the solution is an ele-
ment of the version space.
It can be shown that other kernel based algorithms,
like for example the hard version of Support Vector
Machines (SVM), whose description is beyond the scope
of the paper, also have solutions in the version space. In
the particular case of SVM this solution is in fact unique
and is the one which maximizes the margin on the
training set [38]. As shown in [26] the center of mass of
the version space, the so called Bayes point (Bp), would
be the optimal choice, even better than SVM (which by
the way can be considered an approximation of the Bp),
with nice theoretical properties in terms of its generali-
zation ability. An algorithm that approximates this opti-
mal Bp solution, the so called Bayes point machine, has
been proposed, which considers the average of the solu-
tions of several runs of the perceptron. Our algorithm,
which is presented in the following, is based on a var-
iant of the Bayes point machine.
Note that when a feature space is characterized by
high dimensionality and the features are considered
independent, i.e. there are many more variables (fea-
tures) than constraints (examples), the task is under
constrained. This often implies that the version space
volume is large and can change extremely both in form
and size depending on which examples are used for
training. It is clear that this produces instability. We will
Table 1 Breast cancer datasets used for the classification
Datasets Samples ER+ samples ER- samples
GSE2990 116 83 33
GSE3494 155 131 24
GSE7390 152 103 49
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see in the following how to add available domain knowl-
edge to introduce structural constraints in the problem
in order to improve robustness of a linear classifier.
Feature ranking
The values wi of a linear classifier represent the degree
of importance and the bias that a given feature i pro-
vides to the decision. High positive (negative) values tell
us that such feature is important to classify an instance
as positive (negative). For this reason, the absolute value
of the weights can also be used as a criterion for feature
ranking.
Similarity matrix integration
When prior knowledge is available providing informa-
tion about gene-gene similarity, this knowledge can be
effectively used by mapping examples into a feature
space where linear solutions preserve these similarities.
Consider a linear transformation of the data via a
matrix P, i.e. j(x) = Px. Now, can we say something
about the desirable properties of j which make the task
of discriminating positive versus negative examples sim-
ple enough in the target space? It is well known that a
measure of the goodness of an embedding is the ratio
between the maximal norm R, the highest norm (or
length) of any example xm, and the margin g of the
examples, namely G = (R/g)2. For separable data, the
margin is defined as the distance between the optimal
separating hyper-plane (SVM) and the examples. In the
case of perceptron classifiers, the value G is also related
to the number of mistakes the perceptron algorithm
makes to converge [37]. These considerations seem to
indicate that the margin of transformed examples should
be large in order to get high performance. However,
when the expected margin (or equivalently, the expected
volume of the version space) is too large, it generally
leads to unstable solutions for small datasets. A solution,
which represents a trade-off between these two (appar-
ently) opposite goals, is to choose an embedding of data
where norm of vectors are as small as possible but data
remain linearly separable. Specifically, we propose to
make a linear embedding of data via a bi-stochastic
matrix. We focus on stochastic matrices because they
have the property to map vectors × into shorter ones
(compression) and thus to make the maximal norm R of
target examples smaller (this is due to the fact that the
eigenvalues of a stochastic matrix are all in [0, 1]). As
we have previously seen, this together with large margin
solutions guarantees a good performance of the
embedding.
Let S be a symmetric similarity matrix with elements
in [0, 1] with 1’s in the diagonal, the associated stochas-
tic matrix P is obtained as in the following:
P = D−1(I + α(S − I)) (2)
where I is the identity matrix, D is a diagonal matrix
with elements corresponding to sums of elements in the
rows/columns of (I+a(S-I)), and a > 0 is a tuning para-
meter. Note that when a = 0, we have P = I and the fea-
ture space coincides with the original space. The
parameter a is fixed according to the best stability per-
formance, measured by the Canberra distance (Equation
15).
Now, let be given a perceptron-like solution in the tar-
get space, then the weight vector can be expressed as a
weighted sum of the examples in feature space, namely
w =
∑
βmϕ(xm), and the following holds:
∣∣wi − wj∣∣ =
∣∣∣∑
m
βm
∑
k
Pikxmk −
∑
m
βm
∑
k
Pjkxmk
∣∣∣ =
=
∣∣∣∑
m
βm
∑
k
(Pik − Pjk)xmk
∣∣∣ =
=
∣∣∣∑
k
(Pik − Pjk)
∑
m
βmxmk
∣∣∣ =
=
∣∣∣(Pi − Pj) · h
∣∣∣ ≤ c ∥∥∥(Pi − Pj)
∥∥∥
(3)
where c ≥ 0 is a constant which does not depend on
indices i and j. Thus, we can see the matrix P as a cod-
ing matrix for genes. Specifically, the i-th gene is codi-
fied by Pi. This result shows that when two genes have
similar codes, the difference in the weight vector cannot
be too large.
It is important to note that this result does not imply
that the same gene will have the same position in the
ranking generated by two independent experiments, i.e.
that the same biomarkers will be selected. The result
above simply means that the relative position of two
similar genes will be similar in the two experiments.
However, if the matrix P contains reliable information,
this should hopefully produce similar lists of biomarkers.
Classification algorithm and biomarker list generation
The proposed algorithm is based on the perceptron
algorithm and resembles the Bayes point machine. The
algorithm starts by mapping data using the matrix P.
The transformed data are standardized by subtracting
from each gene expression value its mean across the
samples and dividing by its standard deviation. Then,
data are randomly split (70% training, 30% test) for a
number T = 1000 of times. For each one of these splits
a run of the perceptron algorithm is performed on its
training data (to increase randomization data are also
shuffled before each perceptron epoch). Thus, for each
split t, a weight vector wt is obtained and normalized to
unitary norm. For each split, the accuracy at is also eval-
uated with respect to the test partition. The final solu-
tion is obtained as the average of weight vectors wt, i.e.
W = AVE(wt).
Note that the expected accuracy of W on new unseen
examples can also be estimated by using available data
with the following method. Let Q be the design matrix
Sanavia et al. BMC Bioinformatics 2012, 13(Suppl 4):S22
http://www.biomedcentral.com/1471-2105/13/S4/S22
Page 4 of 11
with entries Qtm = 1 if the example xm is in the training
partition of split t, and 0 otherwise. For each example
xm a predictor W(m) = AVE(wt) is built using just the
weights wt such that Qtm = 0, i.e. we take the average of
the weight vectors for the construction of which the
example xm was not used. Finally, the classifier W(m) is
tested against xm. It is easy to see that the accuracy we
observe applying this method on all available data is an
estimate of the expected accuracy of W. The list of bio-
markers returned by the algorithm is the list of genes
ordered according to the absolute value of their corre-
spondent value in W.
The method described above can also be seen as a
leave-one-out estimate of the accuracy. However, the
same method can be easily adapted to a (k-fold) cross-
validation type of analysis. In this case, the overall pro-
cedure would change as in the following: (i) Split data
in k sets X1,.., Xk; (ii) Train models W1,.., Wm, where Wt,
t = 1,..,k, is learned on the set X\Xt, with the method
presented above, and get the accuracy ACC(Xt) on the
set Xt; (iii) Evaluate the overall accuracy as the average
of these partial accuracy estimates.
The advantage of using a k-fold type of analysis
instead of the leave-one-out type of analysis is its lower
variance for small samples. The disadvantage is that the
method is more computational demanding. We have
done some experiments using both methods and we
have not observed big differences in the obtained results
with our data.
Similarity matrices
Three different kinds of data were considered as prior
knowledge to be integrated in the feature ranking: 1)
Gene Ontology functional annotations; 2) the network
of protein-protein interactions; 3) gene expression pro-
files from a collection of breast cancer studies. All these
data were used to calculate different kinds of similarity
measures sij between pairs of features i and j based on:
• Semantic similarity of functional annotations;
• Topological similarity in the network of protein-pro-
tein interactions;
• Correlation between gene expression profiles.
The corresponding similarity matrix S for N variables
is the symmetric N·N matrix whose element sij refers to
the similarity between the features i and j.
In the following, the methods for codifying the three
types of prior knowledge into the corresponding similar-
ity matrices are described in details. Since in this work
we are considering Affymetrix data, indexes i and j refer
to probesets. What follows can be easily generalized to
consider genes or proteins. Each subsection first
describes the biological information and then illustrates
the metrics used to generate the corresponding similar-
ity matrix.
Semantic similarity
Gene Ontology (GO) is the most widely used annotation
database that collects biological information on gene
products. This controlled vocabulary consists of three
independent categories: molecular function, biological
process and cellular component [19]. GO terms are
organized in a directed acyclic graph (DAG) in which
each node corresponds to a GO term. Each node may
have multiple parents: nodes farther from the root (high
level nodes) correspond to more specialized terms,
nodes closer to the root (low level nodes) to less specia-
lized terms, thus implying that genes annotated with a
specific node are also annotated with every ancestor of
that node (true path rule).
In this work molecular function and biological process
GO annotations related to the probesets were downloaded
from NetAffx database [39], while the DAG structure was
extracted from the Bioconductor package GO.db.
Semantic similarity was used to assess the degree of
relatedness between two features by assigning a metric
based on the likeness of the semantic content of their
GO annotation. An information-theoretic method, based
on the concept of Information Content (IC), was
adopted [40].
The IC for the GO term t is defined as:
IC(t) = − log
(
freq(t)
freq(root)
)
(4)
i.e. the negative logarithm of the ratio between the fre-
quency of the term tF in a corpus of annotations (i.e.
the number of times the term t and each of its descen-
dants occur in GO annotation) and the frequency of the
root term (corresponding to the sum of the frequencies
of all GO terms). The IC decreases monotonically when
moving from the leaves toward the root node (IC = 0).
The intuition behind the use of the IC is that the more
probable a concept is, the less information it conveys.
The Best-Match Average (BMA) approach [41] was
used to calculate the semantic similarity scores sij
between two features i and j:
sij =
1
|GOi|
∑
t∈GOi
maxu∈GOjSimLin(t, u) +
1∣∣GOj∣∣
∑
u∈GOj
maxt∈GOiSimLin(u, t)
2
(5)
where GOi and GOj are the groups of GO terms t and
u associated to the features i and j, respectively and
SimLin(t, u) is the Lin’s similarity measure [42], which
exploits the IC of the two GO terms t and u to generate
normalized similarity measures in the range [0, 1],
according to the following equation:
SimLin(t, u) =
2IC(MICA(t, u))
IC(t) + IC(u)
(6)
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where MICA indicates the most informative common
ancestor. The BMA approach (Equation 5) is able to
robustly assess the global similarity between two fea-
tures also when they are annotated to a different num-
ber of GO terms, since it considers both the GO terms
they share and the GO terms in which the features dif-
fer, but only the most similar ones are matched [22].
Topological similarity
Topological information on PPI was extracted from
HPRD [25]. This repository contains manually curated
scientific information pertaining to the biology of most
human proteins and is the database that includes most
human protein-protein interactions, as shown in [43].
The 22207 features in our datasets were mapped into
9521 proteins using RefSeq identifiers; this resulted in
37080 interactions. Since different proteins can be asso-
ciated to different probesets, the value of the similarity
score sij between probesets i or j was obtained by aver-
aging the similarity scores of the associated proteins:
sij =
1
|Pi|
∑
pi∈Pi
maxpj∈Pj
{
s
(
pi, pj
)}
+
1∣∣Pj∣∣
∑
pj∈Pj
maxpi∈Pi
{
s
(
pj, pi
)}
2
(7)
where Pi and Pj are the sets of proteins pi and pj
annotated to the probesets i and j, respectively.
Four topological measures were used to calculate the
topological similarity scores s(pi, pj) between pairs of
proteins pi and pj: 1) normalized geodesic distance; 2)
Jaccard coefficient; 3) functional similarity; 4) a probabil-
istic common neighborhood similarity.
In order to describe the four topological similarity
measures considered in this study, we first introduce
some terms and notations. The network of the interac-
tions is defined as graph G = (V, E) consisting of a set
of nodes V and a set of edges E between them. pi and pj
refer to proteins which are the nodes of the network; N
(pi) and N(pj) are the neighbors of pi and pj respectively,
and N(pi, pj) = N(pi)∩ N(pj).
Normalized geodesic distance The normalized geode-
sic distance (NG) between two proteins pi and pj is
defined as the normalized length of the shortest path, l
(path(pi, pj)), from pi to pj , obtained by dividing l(path
(pi, pj)) by the maximum of the shortest paths between
all pairs of proteins. The similarity s(pi, pj) between
two proteins is derived as 1 minus the normalized
shortest path:
s(pi, pj) = 1 −
l
(
path
(
pi, pj
))
max
pk ,pr∈V(G)
{
l
(
path
(
pk, pr
))} (8)
Jaccard coefficient The similarity measure s(pi, pj)
based on the Jaccard coefficient (JA) [44] is defined as
the ratio between the number of neighbors which two
proteins share (common neighbors) and the total num-
ber of proteins they are connected to:
s(pi, pj) =
∣∣N(pi, pj)∣∣∣∣N(pi) ∪ N(pj)∣∣ (9)
Functional similarity The functional similarity (FS)
proposed in [23] measures the common neighborhood
similarity of two proteins pi and pj in the network G, as:
s(pi, pj) =
2
∣∣N(pi, pj)∣∣∣∣N(pi) − N(pj)∣∣ + 2 ∣∣N(pi, pj)∣∣ + λij ×
2
∣∣N(pi, pj)∣∣∣∣N(pj) − N(pi)∣∣ + 2 ∣∣N(pi, pj)∣∣ + λji (10)
where
λij = max
(
0,navg −
(∣∣N(pi) − N(pj)∣∣ + 2 ∣∣N(pi, pj)∣∣)) (11)
and navg is the average number of neighbors of pro-
teins in the network. The term lij penalizes the score
between protein pairs where at least one of the proteins
has too few neighbors.
Probabilistic common neighborhood similarity A
probabilistic measure for the statistical significance (SC)
of the common neighborhood configuration of two pro-
teins pi and pj has been recently proposed [24]. The
measure is defined as the negative logarithm of the
probability of pi and pj having a certain number of com-
mon neighbors by random chance:
s(pi, pj) = −log10
(
prob
(
N,
∣∣N(pi)∣∣ , ∣∣N(pj)∣∣ , ∣∣N(pi, pj)∣∣)) (12)
N is the total number of proteins in the network, and
prob(N, |N(pi)|, |N(pj)|, |N(pi, pj)|) is computed on the
basis of the Hypergeometric distribution:
prob
(
N,
∣∣N(pi)∣∣ , ∣∣N(pj)∣∣ , ∣∣N(pi, pj)∣∣) =
min(|N(pi)|,|N(pj)|)∑
k=|N(pi,pj)|
(∣∣N(pi)∣∣
k
)( |N| − ∣∣N(pi)∣∣∣∣N(pj)∣∣− k
)
( |N|∣∣N(pj)∣∣
) (13)
Thus, the higher the probability (13), the higher the
value of s(pi, pj) is.
Equations (8), (9), (10) and (12) are finally used to
derive sij using Equation (7).
Correlation based similarity
Publicly available data from ten breast cancer microar-
ray studies were extracted from GEO, selecting those
with a medium to large sample size (Table 2). Redun-
dant subjects were removed. All datasets were hybri-
dized using Affymetrix U133 Genechips™ (HG-U133A
and HGU133plus2) and were analyzed using A-MAD-
MAN, an open source web application, which allows the
retrieval, annotation, organization and meta-analysis of
gene expression [45]. In particular, the software enables
the integrative analysis of data obtained from different
Affymetrix platforms through meta-normalization. Affy-
metrix chip definition files were used to annotate the
arrays and gene expression intensity signal was
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normalized using RMA algorithm [36]. The resulting
gene expression matrix collects the expression levels of
21921 probesets over 1586 biological samples.
Gene expression profiles over the ten datasets were
compared using similarity measures based on Pearson
correlation coefficient (PE), Spearman rank correlation
coefficient (SP) and Mutual Information (MI), which
provide a general measure to analyze dependencies in
gene expression data [46-48].
Using both the Pearson and the Spearman correlation,
the similarity sij between two probesets i and j was
defined as:
sij =
∣∣ρij∣∣ (14)
To calculate Mutual Information we needed to quan-
tize data on L intervals. There is no optimal solution to
choose L, since it depends on data normalization and on
the particular biological application [49]. As suggested in
[47], heuristic lower/upper bounds on the number of
intervals were considered [50,51]: MIlow = ⌊1+log2m⌋
and MIup = √m, where m is the number of expression
values. In our case, L = 25.
Evaluation of the biomarker lists
Results were evaluated in terms of both stability of the
biomarker lists obtained by the Canberra distance [7]
and the accuracy performed by the perceptron classifier.
Given two ordered lists T1 and T2 of p ranked fea-
tures, the Canberra distance between them is defined as:
Ca (T1,T2) =
p∑
i=1
|τ1 (i) − τ2 (i)|
τ1 (i) + τ2 (i)
(15)
where τ1(i) and τ2(i) indicate the rank, i.e. the position,
of the feature i in the ordered lists T1 and T2,
respectively.
This measure is a weighted version of the Spearman’s
footrule which considers the variations in lower portions
of the lists less relevant than those in the top [7]. A nor-
malized version of this measure can be obtained by
dividing the distance in (15) by its expected (average)
value, approximated by (log(4) -1)p + log(4) - 2 for the
complete lists. The normalized Canberra distance ranges
between 0 (maximal stability) and 1.4 (maximal instabil-
ity), with 1 in the case of randomly generated lists.
The average number of iterations needed by the per-
ceptron in the algorithm is also considered as a good
indicator of the ratio between the maximal norm of
transformed vectors and the margin one can obtain in
feature space. We consider this value as a measure of
how much difficult is the transformed task.
Ranked feature lists obtained using different similarity
matrices were evaluated both within datasets, i.e. com-
paring the 1000 different lists obtained using Bootstrap,
and between datasets, i.e. comparing the global lists
obtained by analyzing datasets GSE2990, GSE3494 and
GSE7390. For the within dataset comparison, the Can-
berra distance was applied on the 1000 complete lists
resulting from the Bootstrap resampling schema adopted
by the classification algorithm. For the between datasets
comparison, the Canberra distance was applied on the
sublists of length k, with k corresponding to the mini-
mum Canberra distance within dataset (average of the
three values obtained for the three datasets). Finally, for
the best performing similarity matrices, the union of the
sublists of length k obtained using the three datasets,
where k ranges from 1 to the maximum number of fea-
tures (22207), was considered in order to quantify the
possible lack of consistency of the global lists.
Results
Within dataset assessment
Table 3 reports the average normalized Canberra dis-
tance and classification accuracy for all the three breast
cancer datasets and for all similarity matrices. Results
are reported for the cases where prior information is
not used (a = 0) and using for each similarity matrix
the value of a (Equation 2) which minimizes the Can-
berra distance. For all the three datasets, all types of bio-
logical information are able to decrease the average
normalized Canberra distance over the biomarker lists
with respect to the standard classification approach. In
particular, three types of prior knowledge are best per-
formers in this task: Gene Ontology Biological Process
(GO BP), Gene Ontology Molecular Function (GO MF)
and protein-protein interactions codified by the normal-
ized geodesic distance (PPI NG). For these three types
of biological knowledge, the improvement in list stabi-
lity, which ranges between 26% and 37%, is achieved
without a corresponding loss in accuracy since this lat-
ter changes in a range between minus 2% to plus 3%.
Table 2 Breast cancer datasets used for the correlation
based similarity
Datasets Platform Samples
GSE2034 [52] HGU133A 286
GSE6532 [53] HGU133A / HGU133plus2 225
GSE11121 [54] HGU133A 200
GSE2990 [30] HGU133A 189
GSE1456 [55] HGU133A 159
GSE7390 [32] HGU133A 155
GSE5460 [56] HGU133plus2 127
GSE3494 [31] HGU133A 110
GSE5847 [57] HGU133A 95
GSE4922 [58] HGU133A 40
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Table 3 also reports the number of iterations needed
by the classification algorithm to reach convergence,
averaged across the 1000 Bootstrap splits. Compared to
other types of prior knowledge, the higher number of
iterations are observed with the correlation (PE and SP)
and Mutual Information (MI) based matrices, whereas
PPI measures lead the classifier to reach convergence
with a lower number of iterations, i.e. they improve
class separability. However, except the normalized geo-
desic distance, all the other protein-protein interaction
measures show the lowest gain in reproducibility.
Between datasets assessment
Table 4 reports the average Canberra distance obtained
by comparing datasets GSE2990 vs GSE3494, GSE2990
vs GSE7390, GSE3494 vs GSE7390, and the resulting
average Canberra distance together with the average clas-
sification accuracy across the three datasets for k corre-
sponding to the minimum Canberra distance within
datasets (average of the three values obtained for the
three datasets). GO BP, GO MF and PPI NG are con-
firmed as the best performing kinds of prior knowledge.
In addition, MI based similarity matrix shows perfor-
mance comparable to the former similarity matrices.
In order to better assess the improvement highlighted
in these four similarity matrices, we have looked at the
size of the union sets of the biomarker lists of length k
over all the three datasets (Figure 1). The more two lists
are similar, i.e. containing the same features, the more
the points of the curve are drawn near the diagonal.
Compared with the standard approach, the union lists
obtained from GO BP, GO MF and PPI NG are able to
improve the feature ranking, but no meaningful
improvements are evident for the similarity matrix
obtained using MI similarity matrix. In particular, the
two GO BP and GO MF based matrices provide the
Table 3 Classification performance within breast cancer datasets
GSE2990 GSE3494 GSE7390
No prior 0.89 (95%)
7
0.93 (93%)
10
0.90 (98%)
6
GO BP 0.62 (93%)
15
0.63 (95%)
21
0.60 (96%)
13
GO MF 0.63 (93%)
17
0.68 (94%)
24
0.60 (97%)
15
PPI NG 0.57 (94%)
10
0.58 (96%)
14
0.53 (97%)
9
PPI JA 0.87 (95%)
7
0.91 (93%)
11
0.87 (97%)
7
PPI FS 0.88 (95%)
7
0.92 (95%)
11
0.88 (97%)
7
PPI SC 0.83 (95%)
8
0.86 (95%)
13
0.83 (96%)
8
PE 0.78 (95%)
49
0.89 (96%)
56
0.79 (96%)
37
SP 0.78 (95%)
48
0.89 (95%)
56
0.79 (95%)
38
MI 0.76 (91%)
130
0.80 (94%)
207
0.73 (94%)
131
Normalized Canberra distance between feature lists obtained for datasets GSE2990, GSE3494 and GSE7390, using the standard classification approach without
prior knowledge integration and different prior knowledge based similarity matrices: Gene Ontology Biological Process (GO BP), Gene Ontology Molecular
Function (GO MF), protein-protein interactions codified by the normalized geodesic distance (PPI NG), the Jaccard coefficient (PPI JA), the functional similarity (PPI
FS), the probabilistic common neighborhood similarity (PPI SC), the Pearson correlation (PE), the Spearman rank correlation (SP) and the Mutual Information (MI).
Predictive accuracy is indicated in brackets, whereas the number of iterations obtained by the classifier is reported below the other scores.
Table 4 Canberra distance and accuracy across breast
cancer datasets
k GSE2990
vs
GSE3494
GSE3494
vs
GSE7390
GSE2990
vs
GSE7390
Mean
Canberra
Distance
Mean
Accuracy
No
prior
4182 0.95 0.94 0.94 0.94 95%
GO BP 4268 0.63 0.65 0.65 0.65 95%
GO MF 3456 0.62 0.62 0.63 0.63 94%
PPI NG 8684 0.62 0.61 0.62 0.62 96%
PPI JA 22207 0.96 0.96 0.97 0.97 95%
PPI FS 22207 0.96 0.97 0.97 0.97 96%
PPI SC 22207 0.91 0.92 0.93 0.93 95%
PE 128 0.70 0.72 0.74 0.74 96%
SP 163 0.68 0.71 0.62 0.62 95%
MI 310 0.62 0.65 0.64 0.64 93%
Pair-wise Canberra distance between the three breast cancer datasets at
different number of features selected according to the minimum Canberra
distance within datasets, using the standard classification approach without
prior knowledge integration and different prior knowledge based similarity
matrices. The corresponding mean value and the mean accuracy obtained
across the three datasets are also reported.
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most stable union lists for k around 5000 features,
whereas PPI NG matrix achieves the best performance
for k around 9000 features.
Discussion
The subject of the investigation in this paper is the effect
of using information from the biological domain into a
learning process with the aim of improving its general per-
formance with respect to the stability of predicted biomar-
kers. State-of-the-art machine learning methods give
solutions with empirically good performance in terms of
accuracy. However, the stability of the selected biomarkers
is also a very important issue. If an accurate system tends
to select the same biomarkers in different independent
experiments, then it is more likely that the selected bio-
markers are the right ones.
In this work, we have integrated gene expression data
and biological prior knowledge to enhance biomarker lists
stability in a classification approach. In particular, we have
compared the effect of incorporating different types of bio-
logical prior knowledge, like functional annotations, pro-
tein-protein interactions and expression correlation
among genes in the learning process by evaluating biomar-
ker list stability and classification accuracy.
Integrating prior knowledge is not an easy task since
different types of information are represented in various
data formats and stored in heterogeneous data structures.
To do that, we have codified biological information into
specific pair-wise similarity measures, chosen accordingly
to the type of biological information used: semantic simi-
larities for the annotations on GO, topology-based simi-
larity measures for PPI and correlation for gene
expression data. Feature space has then been mapped
into a new space in which the more similar two features
are, the more closely they are mapped. Our intuition is
that when some features are strongly correlated to each
other, for example because they belong to the same bio-
logical process, then they likely have similar importance
and are equally relevant for the task at hand. In other
words, the weight vector obtained for a classification task
should have similar values on indices relative to similar
genes. Following this intuition, we can bias the solutions
to fulfill this property. Experimental results seem to sup-
port this intuition: our approach improves list stability,
preserving high classification accuracy. In particular,
three similarity matrices, based on GO BP, GO MF anno-
tations and PPI NG, are the best performers in improving
list stability. The lowest gain in biomarker list reproduci-
bility is observed with the other matrices based on pro-
tein-protein interaction networks, whereas those based
on correlation and mutual information achieve a better
reproducibility but lead the classifier to reach conver-
gence with a higher number of iterations.
In particular, the MI based matrix shows performance
comparable to GO BP, GO MF and PPI NG based
matrices when list stability is assessed between datasets.
Figure 1 Feature list stability. Number of features in the union lists of length k, obtained by the standard classifier (No prior) and the
integration of the best performing biological information: GO Biological Process (GO BP), GO Molecular Function (GO MF), protein-protein
interactions codified by the normalized geodesic distance (PPI NG) and mutual information for gene expression data (MI).
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This work compares the use of different biological
information from genomic databases in the learning
process. The technique proposed in this paper builds a
kernel matrix from a similarity matrix, thus it can be
used together with any kernel method (see [38] and
references therein for a survey). In particular, it provides
a standardized way to incorporate different types of bio-
logical knowledge in the kernel, with the only constraint
that the information is codified by a similarity matrix.
Obtained results provide a starting point for additional
experiments. As future work, we think it would be inter-
esting to combine similarity matrices in order to obtain
even more stable biomarkers, using for example the
approach proposed by Bie et al. [28] to combine kernels.
We believe that the power and potential of the proposed
strategy will increase as the coverage and quality of bio-
logical databases improve.
List of abbreviations used
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